Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis

OBJECTIVE: To evaluate whether the use of dipeptidyl peptidase-4 (DPP-4) inhibitors and their cardiac tissue distribution profile and anticalcification abilities are associated with risk of aortic stenosis (AS) progression. METHODS: Out of the five different classes of DPP-4 inhibitors, two had rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sahmin, Lee, Seung-Ah, Choi, Bongkun, Kim, Ye-Jee, Oh, Soo Jin, Choi, Hong-Mi, Kim, Eun Kyoung, Kim, Dae-Hee, Cho, Goo-Yeong, Song, Jong-Min, Park, Seung Woo, Kang, Duk-Hyun, Song, Jae-Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Valvular Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677484/
https://www.ncbi.nlm.nih.gov/pubmed/32917732
http://dx.doi.org/10.1136/heartjnl-2020-317024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677484/
https://www.ncbi.nlm.nih.gov/pubmed/32917732
http://dx.doi.org/10.1136/heartjnl-2020-317024

Ejemplares similares